Company Analysis

MannKind Corporation (MNKD)

Nasdaq: MNKD · Pharmaceutical Preparations · Danbury, CT · filing with the SEC since 2004
Grade6.2
◀ Past 6.3● Present 6.4▶ Future 5.9

The grade of MannKind Corporation

Nine metrics read from its own filings, by tense
Headline grade
6.2/10
◀ Past6.330% of the headline
● Present6.440% of the headline
▶ Future5.930% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

All nine metrics read as filed from the record.

◀ Past

What did they actually do?

6.3/1030% of the headline grade · 3 of 3 filed

Surviving crises

as filed
8.2/10

Has it survived what it has been through?

No warning events in its filings since 2017.

weight 33% of this tense · 82nd percentile among 497 sector filers · read for itself

From the record

MannKind Corporation's filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed
5.8/10

What has it actually done, year after year?

+8% a year over 10 filed years; profitable in 3 of 10.

weight 45% of this tense · 58th percentile among 323 sector filers · read for its customers

From the record

MannKind Corporation's 10 filed years say what it did: revenue went from $175 million in fiscal 2016 to $349 million in fiscal 2025, up 8% a year; it rose in 8 of 9 years; the deepest fall was 93% from fiscal 2016 to fiscal 2017; net income was positive in 3 of 10 of those years (its annual reports).

What it rests on

  • revenue growth over the filed span8.0%bottom 41% of its family
  • the share of years revenue rosetop 18% of its family
  • the share of filed years with a profittop 22% of its family
  • the deepest fall from a revenue peak93.3%bottom 31% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

as filed
4.6/10

How has it treated the people who own it?

Share count grew 6.9% a year. 0% of cash flow returned. Insiders: 14 sales, 1 purchases.

weight 22% of this tense · 46th percentile among 80 sector filers · read for its shareholders

From the record

Over the 3 fiscal years to 2025-12-31, MannKind Corporation's diluted share count grew about 6.9% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 14 sales (14 under scheduled 10b5-1 plans) and 1 purchase of their own stock on the open market in the year to 2026-09-30, buying about $259 thousand (their Form 4 filings).

What it rests on

  • the share count over the yearstop 29% of its family
  • cash returned against operating cash flowbottom 20% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

● Present

What are they doing right now?

6.4/1040% of the headline grade · 3 of 3 filed

Financial health

as filed
4.7/10

Is it financially healthy right now?

Leverage 106%: owes 106¢ per asset dollar.

weight 45% of this tense · 47th percentile among 473 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, MannKind Corporation's shareholders' equity was below zero, so the profit on it is not read, and gross profitability: its products earned about 41 cents per dollar of everything the company owns (revenue less the cost of revenue). Leverage: it owed about 106 cents per dollar of assets, and net share issuance: its share count grew 10.7% over the year (the filed statements).

What it rests on

  • what it owes per dollar of assetsbottom 10% of its family
  • gross profit against assetstop 28% of its family
  • the share count against the year beforetop 39% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed
7.7/10

How strong is its position in its industry?

top 23% of 315 in its family; net margin 1.7%.

weight 33% of this tense · 77th percentile among 315 sector filers · read for its customers

From the record

MannKind Corporation's standing among 315 graded names in its industry family: revenue of $349 million in fiscal 2025 ranks in the top 22% by size; a net margin of 1.7% ranks in the top 23%; revenue growth of 51.8% a year over the last 3 filed years ranks in the top 24% (its annual reports).

What it rests on

  • revenue against the family$349Mtop 22% of its family
  • net margin1.7%top 23% of its family
  • three-year revenue growth51.8%top 24% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

as filed
7.9/10

What are the people in charge doing?

top 21% of 315 in its family for leadership; chief executive since 2017.

weight 22% of this tense · 79th percentile among 315 sector filers · read for its shareholders

From the record

MannKind Corporation's leadership, from its insiders' filings and its current reports: the chief executive on the record is Castagna, Michael (Chief Executive Officer, as filed), filing under that title since 2017-06-14, 9.4 years (top 18% of its family); the 15 officers and directors filing in the last fifteen months have been on the record a median of 7.7 years (top 21%); 4 officer or director changes were reported on Form 8-K since 2023-11-13, against the 15 people in charge now (top 25%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

What it rests on

  • officer and director changes on Form 8-K, against the people in charge4 in three years among 15 peopletop 25% of its family
  • the median years the people in charge have filed7.7 yearstop 21% of its family
  • the chief executive's years on the record9.4 yearstop 18% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

▶ Future

What are they set up to do next?

5.9/1030% of the headline grade · 3 of 3 filed

Room to expand

as filed
4.8/10

How much room does it have to grow?

bottom 48% of 273 in its family for room to expand.

weight 45% of this tense · 48th percentile among 273 sector filers · read for itself

From the record

MannKind Corporation's room to grow, from the newest filed statements (fiscal 2025): cash of $75 million against debt of $355 million leaves -35.3% of its assets as net cash, bottom 3% of its family; cash from operations less capital spending is 3.9% of revenue (top 26%); a gross margin of 92.3% (top 11%); research spending of 19% of revenue (bottom 24%) (its annual report).

What it rests on

  • cash less debt against assets-35.3%bottom 3% of its family
  • cash from operations less capital spending against revenue3.9%top 26% of its family
  • gross margin92.3%top 11% of its family
  • research spending against revenue19.0%bottom 24% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed
7.4/10

What could actually drive growth from here?

top 26% of 306 in its family for growth drivers.

weight 33% of this tense · 74th percentile among 306 sector filers · read for its customers

From the record

MannKind Corporation's growth drivers, from the filed years to fiscal 2025: revenue grew 51.8% a year over the last three filed years against 8% over all 10, speeding up (top 10% of its family); the newest year grew 22.2% (top 36%); research spending grew 49.8% a year (top 8%); capital spending grew -15.6% a year (bottom 50%) (its annual reports). MannKind Corporation reported 5 product lines in fiscal 2025: Royalty at $128 million (36%), Product at $114 million (32%), License and Service at $107 million (30%), and 2 more; 3 of 5 grew against the year before (its annual report).

What it rests on

  • three-year growth against the whole span+43.8 points a yeartop 10% of its family
  • the newest year's revenue growth22.2%top 36% of its family
  • three-year growth of research spending49.8%top 8% of its family
  • three-year growth of capital spending-15.6%top 50% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

as filed
5.8/10

Did its newest year beat what its own record pointed to?

top 42% of 233 in its family for expectations against reality.

weight 22% of this tense · 58th percentile among 233 sector filers · read for its shareholders

From the record

MannKind Corporation's newest year against its own record: revenue of $349 million in fiscal 2025 came in 27.7% below the $483 million its prior three years' pace pointed to (bottom 28% of its family); net income of $6 million against a prior three-year average of $24 million (top 13%); a net margin of 1.7% against -28% before (top 42%) (its annual reports).

What it rests on

  • revenue against the prior three years' pace-27.7%bottom 28% of its family
  • net income against the prior three years' average+125%top 13% of its family
  • net margin against its prior average+29.7 pointstop 42% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton MNKD · research, not advice